India Policy Document
Guidelines for Evaluation of Nanopharmaceuticals in India
2017| Policy Type | Regulation |
|---|---|
| Coverage Level | National |
| Policy Sector | Medicine |
| ELSA-HSE Issues | Safety |
PUBLISHER (s)
- Indian Society of Nanomedicine
PUBLISHERS
|
|
Indian Society of Nanomedicine |